Koyfin Home > Directory > Health Care > Revance Therapeutics > Diluted Shares Outstanding

Revance Therapeutics Diluted Shares Outstanding Chart (RVNC)

Revance Therapeutics annual/quarterly Diluted Shares Outstanding from 2012 to 2020.
  • Revance Therapeutics Diluted Shares Outstanding for the quarter ending September 09, 2020 was $61m a 24.62% increase of 15m year over year
  • Revance Therapeutics Diluted Shares Outstanding for the last 12 months ending September 09, 2020 was $54m a 18.90% increase of 10m year over year
  • Revance Therapeutics Annual Diluted Shares Outstanding for 2019 was $43m a 16.77% increase of 7m from 2018
  • Revance Therapeutics Annual Diluted Shares Outstanding for 2018 was $36m a 16.78% increase of 6m from 2017
  • Revance Therapeutics Annual Diluted Shares Outstanding for 2017 was $30m a 6.60% increase of 2m from 2016
Other Per Share Metrics:
  • Revance Therapeutics Diluted EPS Excl. Extra Items for the quarter ending December 12, 2018 was $-1m a 12.98% decrease of 0m year over year
  • Revance Therapeutics Diluted EPS Incl. Extra Items for the quarter ending December 12, 2018 was $-1m a 12.98% decrease of 0m year over year
View Chart On Koyfin

Quarterly RVNC Diluted Shares Outstanding Data

09/2020$61m
06/2020$54m
03/2020$54m
12/2019$46m
09/2019$43m
06/2019$43m
03/2019$42m
12/2018$36m
09/2018$36m
06/2018$36m

Annual RVNC Diluted Shares Outstanding Data

2019$43m
2018$36m
2017$30m
2016$28m
2015$24m
2014$19m
2013$1m
2012$0m
2011$0m